scispace - formally typeset
B

Brenda Bradley

Researcher at University of Colorado Denver

Publications -  18
Citations -  1808

Brenda Bradley is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: NOD mice & Islet. The author has an hindex of 16, co-authored 18 publications receiving 1595 citations. Previous affiliations of Brenda Bradley include Anschutz Medical Campus & University of Montana.

Papers
More filters
Journal ArticleDOI

Chromogranin A is an autoantigen in type 1 diabetes

TL;DR: The peptide WE14 from chromogranin A (ChgA) is identified as the antigen for highly diabetogenic CD4+ T cell clones in the nonobese diabetic (NOD) mouse model of type 1 diabetes and supports the idea that autoreactive T cells respond to unusually presented self peptides.
Journal ArticleDOI

Oxidative Stress in Type 1 Diabetes

TL;DR: It is demonstrated that treatment of prediabetic NOD mice for 2 weeks with a metalloporphyrin superoxide dismutase (SOD) mimetic results in marked reduction of oxidative stress in islets and vascular tissue and a reversal of macrophage defects.
Journal ArticleDOI

T-lymphocyte clone specific for pancreatic islet antigen.

TL;DR: It is suggested that the islet-specific T-lymphocytes mediate islet destruction in a tissue-specific manner in an in vivo transplantation system in which islet grafts were made in the presence or absence of the BDC-2.5.
Journal ArticleDOI

PEG-based hydrogels as an in vitro encapsulation platform for testing controlled β-cell microenvironments

TL;DR: The compatibility of the PEG encapsulation system with freshly isolated islets was confirmed and encapsulated MIN6 beta-cells transplanted into diabetic mice returned blood glucose levels to normal levels, indicating in vivo function.